Randomized into 2 rehabilitation groups—traditional (n = 10) and ASTM AdvantEDGE (n = 10).
Main Outcome Measures:
Clinical data and self-reported questionnaires collected at 0, 6, and 12 weeks.
On completion of the 6th week, 100% of the ASTM AdvantEDGE group and 60% of the traditional group had resolved. The unresolved subjects were crossed over to the ASTM AdvantEDGE for additional therapy. At the end of the additional therapy, 50% of the crossover subjects had resolved. The ASTM AdvantEDGE group's clinical outcomes and weekly journals indicated a statistically significant (P = .04) improvement in subjective pain and functional-impairment ratings.
Findings suggest that ASTM AdvantEDGE resulted in improved clinical outcomes in treating patellar tendinitis.
Wilson, Sevier, and Honing are with Central Indiana Orthopedics and Sports Medicine, Muncie, IN 47304. Helfst and Thomann are with CHS HealthStrategies, Muncie, IN 47302.